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The Clade B lineage of the New World arenaviruses contains four viruses capable of causing severe hemorrhagic fevers in humans. Within this
group, the B1 sub-lineage contains the pathogenic viruses Junin (JUNV) and Machupo (MACV), as well as the non-pathogenic Tacaribe virus
(TCRV). In order to elucidate differences that may determine pathogenicity, we studied the entry pathways directed by the glycoproteins (GPs)
from these related B1 viruses, using pseudotyped retroviral vectors and GP1 immunoadhesin constructs. Our data revealed variations in the
efficiency with which different cell types could be transduced by B1 vectors, and this correlated with the ability of the immunoadhesins to bind to
those cells. Interestingly, the tropism directed by the TCRV GP proved to be distinct from that of JUNV and MACV, in particular on lymphocyte
cell lines. In addition, the GPs showed variations in their sensitivity to an inhibitor of endosome acidification, with the TCRV GP again being the
outlier. Together these data suggest that more than one entry pathway can be used by these closely related viruses and that the ability to cause
human disease may be highly dependent on receptor usage.
© 2007 Elsevier Inc. All rights reserved.Keywords: Arenavirus; Junin; Machupo; Tacaribe; Cell receptor; TropismIntroduction
The arenaviruses are rodent-borne, single-stranded, envel-
oped RNA viruses. Five out of the twenty-two known members
of this family cause severe hemorrhagic fevers in humans, with
fatality rates up to 20% (Geisbert and Jahrling, 2004), leading to
their classification by the Centers for Disease Control and
Prevention as Category A pathogens. They express four genes
from a genome that consists of two ambisense strands of RNA.
The viral glycoprotein (GP) alone is sufficient to direct the entry
of these viruses into cells and retroviral vectors pseudotyped
with GPs can recapitulate the entry pathway of the viruses
(Reignier et al., 2006).⁎ Corresponding author. Department of Research Immunology and Bone
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doi:10.1016/j.virol.2007.03.003The arenaviruses are classified into two major groups, the
Old World and the New World/Tacaribe complex viruses. The
New World viruses are further subdivided into three Clades,
with the Clade B lineage of particular interest since it contains
four of the five significant human pathogens: Junin (JUNV),
Machupo (MACV), Guanarito (GTOV) and Sabia viruses.
These pathogens cause hemorrhagic fevers in Argentina,
Bolivia, Venezuela and Brazil respectively, with the different
geographical distributions of the viruses reflecting the habitats
of their rodent hosts.
Phylogenetic analysis of the Clade B viruses revealed that
the human pathogens do not group together but are distributed
in 3 different sub-lineages, together with non-pathogenic
members (Bowen et al., 1996; Charrel et al., 2002). For
example, although JUNV and MACV are closely related, they
also share a common ancestor with Tacaribe virus (TCRV) in
the B1 sub-lineage (Fig. 1). JUNV and MACV both cause
severe hemorrhagic fevers in humans and are transmitted by
Fig. 1. Phylogeny of Clade B arenaviruses. The strains that are pathogenic for
humans (boxed) are distributed among the three sub-lineages. The image was
adapted from phylogenetic analysis of amino acid sequences in GP based on
pairwise distance algorithm and the neighbor-joining method, presented in
Charrel et al., 2002.
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spp. bats in Trinidad in the 1950s (Downs et al., 1963) and is
unusual among the arenaviruses in having a non-rodent
reservoir. Within the amino acid sequences of their respective
GPs, JUNV and MACV are 69.4% identical, JUNV and TCRV
are 65.3% identical, and MACVand TCRVare 61.3% identical.
Despite the close relationship of TCRV with JUNVand MACV,
it is not associated with human infections (Price, 1978), apart
from occasional laboratory-acquired infections (Peters et al.,
1996).
It is becoming apparent that members of the arenavirus
family have evolved to use more than one cellular receptor, and
that differences in receptor usage and tropism can have a
profound influence on the ability of the viruses to cause human
disease (Smelt et al., 2001). While the Old World arenaviruses
Lassa fever virus (LASV) and lymphocytic choriomeningitis
virus (LCMV) can use α-dystroglycan (α-DG) as a cellular
receptor, previous studies from our group and others have
shown that the NewWorld Clade B viruses do not require α-DG
to enter cells (Reignier et al., 2006; Rojek et al., 2006;
Spiropoulou et al., 2002). Specifically, in mouse embryonic
stem cells, the ability of retroviral vectors pseudotyped with
Clade B GPs to transduce those cells was unaffected by a
homozygous gene disruption of dystroglycan (Reignier et al.,
2006; Rojek et al., 2006). Further characterization of the nature
of the alternative receptor(s) used by pathogenic Clade B
viruses has determined that it is a protein, and that infection is
not dependent on modification by N-glycans, O-glycans or
glycosaminoglycans (Rojek et al., 2006). It has also been
suggested that the non-pathogenic B2 virus, Amapari (AMAV),
uses a different receptor than JUNV, MACVor GTOV, since it
shows distinct tropism patterns on a variety of cell lines and
inactivated AMAV is unable to block transduction by JUNV,
MACV or GTOV pseudotyped vectors (Rojek et al., 2006).
We have previously reported that retroviral vectors pseudo-
typed with the GPs from JUNV and MACV display broad
tropism, being able to transduce cell lines from a range of
different species and tissue types (Reignier et al., 2006).
However, we also observed variation in the efficiencies with
which the different GP pseudotypes were able to transduce
certain cell lines, with rodent cells in particular highlighting
those differences. We hypothesized that this could be caused by
the use of different receptors or co-receptors within the Clade B
group or, alternatively, because of differential sensitivity to theform of a common receptor as it is presented on diverse cell
lines. Such differences could include absolute levels of the
receptor, differences at the primary amino acid sequence level,
or be due to variations in post-translational modifications.
There is a precedent for the latter, since differences in the
glycosylation state of dystroglycan are thought to underlie the
inability of LASV and LCMV to infect human lymphocytes
(Imperiali et al., 2005; Kunz et al., 2005; Reignier et al.,
2006).
We here report differences in the tropism directed by the GPs
from the B1 lineage on cell lines from different species. In
particular, we found striking differences between the GPs from
the pathogenic B1 viruses, JUNV and MACV, compared to the
related non-pathogenic virus TCRV, in their abilities to direct
entry into human and mouse lymphocytes. This suggests that
either these closely related viruses can utilize different primary
receptors or co-receptors, or that if using a single common
receptor for entry, that the viruses have evolved different
requirements of that receptor. This, in turn, could underlie the
differences in their ability to jump the species barrier and cause
disease in humans.
Results
Retroviral vectors pseudotyped with Clade B1 glycoproteins
display distinct tropism patterns
The GPs of the B1 arenaviruses JUNV, MACV and TCRV
are closely related at the sequence level and constitute the B1
sub-lineage within the Clade B arenaviruses (Fig. 1). We have
previously observed that retroviral vectors pseudotyped with
the GPs from JUNV and MACVare able to transduce cell lines
from a range of different species and tissue types, although we
also found some differences in their relative efficiencies
(Reignier et al., 2006). To explore this further, we examined
the titers of green fluorescent protein (GFP)-expressing retro-
viral vectors pseudotyped with the three B1 GPs on an
expanded panel of cell lines. As a control we included vesicular
stomatitis virus G protein (VSV G) pseudotyped vectors
because VSV G is known to have an extremely broad tropism
and therefore provides a control for the level of transduction
directed by the retroviral vector machinery in each cell line.
The efficiency of entry directed by each vector type was
measured by FACS analysis of target cells 48 h post-
transduction, with up to 100,000 cells analyzed to ensure that
even rare events could be detected. All of the vector stocks were
initially titered on 293A cells, which are very permissive to all
of the arenavirus GP pseudotypes that we have examined. The
panel of test cell lines included various human and rodent cell
lines, as well as one bat cell line (Fig. 2).
Examination of the data revealed several patterns. First, on
the human cell lines, the B1 GPs directed similar titers (within
the same order of magnitude) on human epithelial (293A) and
erythroleukemia (K562) cells. However, on the human T
lymphocytic cell line, CEM, we found that while the JUNVand
MACV vectors gave titers of approximately 1×104 transducing
units per milliliter, the TCRV vectors gave no titer.
Fig. 2. Titers of pseudotyped retroviral vectors on (A) human, (B) rodent and (C) bat cells. Titer was calculated by FACS analysis of cells for GFP expression 48 h after
transduction, and is expressed as transducing units (TU) per milliliter. The values shown are the mean±SEM for 3–6 independent experiments. ⁎, No titer detected.
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but consistent pattern for the B1 GP vectors. Here, the MACV
GP was typically one order of magnitude less efficient at
directing entry than either the JUNVor TCRVGPs on the mouse
(mES DG-, NIH3T3), Chinese hamster (CHOK1) and rat (IEC-
6) cell lines examined. An outlier to this general pattern was the
mouse T lymphocyte cell line, TIB27, where neither JUNV nor
MACV vectors gave any titers, while the TCRV vectors resulted
in a low but consistently positive titer. The single bat cell line that
we examined (lung epithelial cells) was equally permissive for
JUNV and MACV vectors, and slightly more so for the TCRV
vectors. Together, these data highlight differences in the
efficiency with which the different B1 GPs can direct entry
into cell lines from different species and tissue types, and also
suggest that human and rodent lymphocyte cell lines in
particular can reveal differences in their requirements for entry.Table 1
Titers of vectors on lymphocyte cell lines
Vector stock 293A human epithelial CEM human T Jurkat human T N
JUNV 2.4×104 4.9×103 5.0×102 1
JUNV (conc.) 2.5×106 NT NT N
MACV 6.0×104 7.7×103 1.5×103 1
MACV (conc.) 1.1×106 NT NT N
TCRV 4.1×104 0 0 0
TCRV (conc.) 1.2×106 0 1.3×101 0
Conc., concentrated vector stocks. NT, not tested.Differences in tropism are most pronounced on human and
rodent lymphocytes
To explore the differences that we had observed in more
detail, we broadened our analysis to include a wider panel of
human and mouse lymphocyte cell lines. We also generated
concentrated stocks of vectors to increase the sensitivity of the
assay, and allow us to be confident of the significance of
relatively low titers. Controls were run to ensure that none of the
titers were due to carryover of GFP or other types of pseudo-
transduction, as have been reported in the literature (Haas et al.,
2000) (data not shown).
As shown in Table 1, the panel of human T and B
lymphocyte cell lines examined showed the same pattern as
the CEM cells, being susceptible to the JUNV and MACV
vectors, while being resistant to the TCRV vectors. Thealm 6 human B TIB27 mouse T TIB53 mouse T CRL 1608 mouse B
.2×102 0 9.8×101 1.6×101
T 0 6.4×101 3.2×101
.8×103 0 0 0
T 0 0 0
4.3×101 3.9×102 2.6×102
1.9×103 NT NT
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from BALB/C strain mice: TIB27 and TIB53 are T
lymphocyte lines derived from a lymphoma and thymoma
respectively, while CRL1608 cells are B lymphoblasts. This
expanded panel revealed further differences in the tropism of
the B1 GPs; in all 3 cases, TCRV pseudotyped vectors were
able to transduce the cells while MACV vectors did not. The
pattern observed with the JUNV vectors was intermediate,
being unable to transduce TIB27 cells, but giving titer on the
other 2 cell types, albeit at very low levels.Fig. 3. GP1 immunoadhesin binding to cells. (A)Western blot of 293Tcell lysates exp
cloning vector alone. The JUNV construct was not detected and is presumably not exp
indicated cell lines. The Fc portion of the immunoadhesin was detected with a goat an
percentage of cells staining positive in each sample is shown. For comparison, the t
+++ is >103 TU/ml,+ is 101 TU/ml.Immunoadhesin binding patterns reflect the observed titer
differences
To investigate whether the differences in tropism we
observed were manifest at a binding or post-binding stage of
the entry process, we next asked if the differences in titer were
also observed at the level of binding/interaction with receptor.
To do this, we constructed a panel of immunoadhesins for the
Clade B1 GPs. These molecules comprise the GP1 subunit of
the arenavirus GP which, by comparison to other class I viralressing immunoadhesins, probed with anti-rabbit IgG antibody. pSK100 is the Fc
ressed or unstable. (B) Binding of LASV, MACVand TCRV immunoadhesins to
ti-rabbit secondary antibody labeled with FITC, followed by FACS analysis. The
able indicates whether the various GP vector/cell combinations resulted in titer:
Fig. 4. NH4Cl sensitivity. Effect of 50 mM NH4Cl treatment on the titer of
indicated vectors on (A) 293A cells, (B) K562 cells and (C) CEM cells. Stocks
of VSV G, JUNV, MACV and TCRV vectors were used that gave titers on
untreated 293A cells that were equivalent to those shown in Fig. 2A; the A-MLV
Env vector stock used had an average titer of 1.6×106 TU/ml on untreated 293A
cells. In each case, the titers obtained in the presence of NH4Cl were made
relative to the values obtained in the absence of the drug (100%). The values
shown are the mean±SEM for n>4 independent experiments.
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and Buchmeier, 1986), fused to the Fc portion of rabbit
immunoglobulin (IgG). Similar constructs have been made
using other viral fusion proteins and show good correlation
between the range of cells that can be infected or transduced and
the binding of the immunoadhesin (Adkins et al., 1997; Jones et
al., 2002). As a control, we also included an immunoadhesin
containing the LASV GP1. Since the GP1 component of each
immunoadhesin is predicted to be extensively glycosylated, the
actual molecular weight of the final immunoadhesins could not
be predicted, but Western blotting of cell lysates revealed Fc-
containing proteins in the expected range of molecular weights
for the MACV, TCRV and LASV immunoadhesins, although
not for JUNV (Fig. 3A). (The yield of immunoadhesins in the
culture supernatant was too low to reliably observe the secreted
proteins by Western blotting.)
Examination of the patterns of immunoadhesin binding
revealed that, in general, the binding activity of the immu-
noadhesins mirrored the titer results we observed (Fig. 3B). For
example, on K562 cells, which are susceptible to transduction
by LASV, MACVand TCRV vectors, all three immunoadhesins
showed good binding. In contrast, human lymphocytes such as
CEM cells showed no binding over the background control
sample for either the LASV or TCRV immunoadhesins, in
agreement with the lack of titer we observed on these cells,
while the MACV immunoadhesin was able to bind to these cells
efficiently. Finally, on the rodent lymphocyte cell line TIB27,
we found that the TCRV immunoadhesin was able to bind,
while the MACV reagent did not, again recapitulating the vector
transduction observations. The only exception to this general
pattern was found with the LASV immunoadhesin and TIB27
cells. Here we observed reasonably good binding by the
immunoadhesin although the titers of LASV GP vectors on this
cell are extremely low (data not shown). Taken together our data
suggest that the different tropism we observe for the Clade B1
GPs is primarily determined at the level of GP1 interaction with
the cell surface receptor.
The pH dependence of B1 entry pathways is cell-type-specific
Viral entry pathways can be classified as pH-dependent or
pH-independent, depending on whether the acidic environment
of an endosome is a necessary condition to trigger virus–cell
fusion (Eckert and Kim, 2001). We examined the requirements
for low pH in the entry pathways directed by the Clade B1 GPs
by measuring the titers achieved in the presence and absence of
ammonium chloride (NH4Cl), a lysosomotropic agent that
blocks endosome acidification. As controls we included VSV G
and amphotropic murine leukemia virus Envelope (A-MLV
Env) pseudotyped vectors, since their entry is known to be pH-
dependent and -independent respectively (Carneiro et al., 2001;
Katen et al., 2001; Nussbaum et al., 1993; McClure et al., 1990).
Cell viability, as analyzed by flow cytometry, revealed no
significant differences between control and treated cells.
When this analysis was performed on human 293A cells
(Fig. 4A), all of the Clade B1 GPs exhibited pH dependence,
with titers dropping one order of magnitude in the presence ofNH4Cl. This is a typical response for a pH-dependent virus
(Katen et al., 2001; Kahn et al., 1999) and a similar drop was
seen for the VSV G control, but not for the A-MLV Env control.
However, when we repeated this analysis using K562 cells, we
found that only TCRV vectors remained strongly pH-depen-
dent, with the JUNV and MACV pseudotyped vectors being
only partially inhibited (40–65%). Finally, analysis on CEM
cells revealed that the B1 viruses that can infect these cells
137J. Oldenburg et al. / Virology 364 (2007) 132–139(JUNV and MACV) are using a pH-sensitive entry pathway.
Together, these findings suggest that the entry pathways
directed by the B1 GPs may differ between the different
viruses, and on different cell types.
Discussion
The tropism or host range of a virus is a key determinant of its
pathogenicity. In the arenaviruses, the Old World viruses LASV
and LCMV, as well as the New World Clade C viruses, are able
to use the broadly expressed cellular protein α-dystroglycan as a
cellular receptor (Cao et al., 1998; Spiropoulou et al., 2002).
LASV in particular seems to be highly dependent on this
molecule (Kunz et al., 2005; Reignier et al., 2006), although
LCMV can clearly use another receptor(s) (Smelt et al., 2001;
Kunz et al., 2004). The other human pathogens in the arenavirus
family reside in the Clade B lineage. The GPs from these viruses
also exhibit broad tropism, suggesting a widely expressed
receptor, but do not requireα-DG for entry (Reignier et al., 2006.
Rojek et al., 2006; Spiropoulou et al., 2002).
In this study, we analyzed the tropism directed by the GPs
from the Clade B1 viruses JUNV, MACV and TCRV. We used
pseudotyped retroviral vectors that act as surrogates for the entry
pathway used by the native viruses, and GP1-Fc immunoadhesin
constructs to study the binding of the GP1 subunit to both
permissive and resistant cell lines. These studies revealed
interesting differences between these three related GPs, both in
their host ranges and the pH sensitivity of the entry pathways that
they use, most notably that the TCRV GP displayed properties
that were distinct from the MACV and JUNV GPs.
The main difference in tropism that we observed among the
B1 viruses was manifest in lymphocytes. Specifically, TCRV
GP pseudotyped vectors could not transduce human B or T cell
lines, while MACV and JUNV vectors could. Conversely,
TCRV vectors could transduce mouse T and B cell lines while
MACV, and to a lesser extent JUNV vectors, were restricted on
these lines. The titer pattern that we observed was mirrored by
the behavior of immunoadhesins containing only the GP1
subunit, with binding efficiency correlating well with titer.
Therefore, GP1 alone is able to bind to cells in a pattern that
recapitulates the tropism of the complete GP when carried by
retroviral vectors. This suggests that the defects in entry we
observed are at the level of binding of GP1 to a receptor.
Differences in the ability of native viruses or pseudotyped
retroviral vectors to enter cells can arise for various reasons. In
the simplest case, it is caused by the absence of the required
cellular receptor or co-receptor on the surface of the cells. Other
possibilities relate to the location of the receptor on a cell, for
example whether it has an apical or basolateral distribution on
polarized cells (Fuller et al., 1984, 1985), and the presence or
absence of any post-translational modifications. We and others
have previously shown that the LASV GP cannot direct entry
into human lymphocytes (Kunz et al., 2005; Reignier et al.,
2006) and it has been suggested that this is due to the
glycosylation state of α-DG in these cells (Imperiali et al., 2005;
Kunz et al., 2005). Lymphocytes exhibit varied glycosylation
states that are related to their differentiation state (Daniels et al.,2002). It is possible therefore that a similar situation exists with
regard to the ability of B1 viruses to use receptors on
lymphocytes. Alternatively, different levels of receptor expres-
sion in these cells may underlie the tropism differences that we
observed.
Viral entry can also be blocked at a post-binding stage, as the
virus-receptor interaction can sometimes lead to sequestration
into non-productive entry pathways (Nilson et al., 1996). In
particular, the fusion proteins from many enveloped viruses
require an additional step in their entry process beyond simple
receptor binding, for example requiring the low pH environ-
ment of an endosome to trigger the post-binding conformational
changes needed for virus–cell fusion (Eckert and Kim, 2001).
Accordingly we examined the pH dependence of B1 entry using
a classic inhibitor of endosome acidification, NH4Cl. Previously
it has been reported that JUNV is sensitive to such inhibitors
(Castilla et al., 1994). In human 293A cells, all of the B1
pseudotyped vectors exhibited the typical one order of
magnitude decrease in titer in the presence of NH4Cl that
indicates a pH-sensitive entry pathway. However, human K562
cells revealed a different pattern, with only the TCRV vectors
remaining strongly pH-dependent among the three Clade B1
GPs. Finally, we also examined the pH sensitivity of entry for
JUNV and MACV vectors on CEM cells (which cannot be
transduced by TCRV vectors). In both cases the vectors were
sensitive to NH4Cl treatment.
It is possible that the different sensitivities to the presence of
NH4Cl that we observed within the B1 GPs arose because of
variations in the stability of these GPs. The ability to complete
entry when NH4Cl is removed will be dependent on the overall
stability of a viral fusion protein, and this can lead to the
appearance of different pH sensitivities. For example, this has
been shown to underlie the differences between the ecotropic
and amphotropic subtypes of MLV Env (Katen et al., 2001),
which had previously been considered pH-dependent and
-independent respectively (McClure et al., 1990). However,
we believe that the situation with the different Clade B1 GPs is
more complicated than this explanation would allow, since the
different responses to NH4Cl treatment were cell line-specific as
well as GP-specific, and are therefore more likely to result from
the use of distinct entry pathways by the GPs, at least in the
K562 cell line. Instead, our findings suggest that JUNV and
MACV may be able to access an alternate, non-pH-dependent
pathway in K562 cells that is not available to the TCRV GP in
these same cells, and which is also not available to any of the
GPs in either 293A or CEM cells.
Overall, we repeatedly observed that the TCRV GP
behaved differently than either the JUNV or MACV GP,
despite the relatedness of these three viruses. It is tempting to
suggest that the acquisition of the ability to use the JUNV/
MACV entry pathway was critical in allowing these viruses to
cross the species barrier and infect humans. Similarly
intriguing are the observations of Rojek et al. (2006), who
reported evidence that the non-pathogenic B2 virus, AMAV,
uses a different receptor than either JUNV, MACV, or the
other known B2 virus, GTOV. Together these findings suggest
that the New World Clade B viruses have evolved to use more
138 J. Oldenburg et al. / Virology 364 (2007) 132–139than one receptor. Whether TACV and AMAV can use the
same alternate receptor, and whether there is a correlation
between receptor use and ability to cause human disease
remains to be seen. But if so, it suggests that receptor use will
be a good predictor of pathogenicity for any new viruses that
may emerge within this family, and that the GP-receptor
interaction will be an important therapeutic target.
Materials and methods
Cell lines
293A, 293T, NIH3T3, CHOK1, TIB27 and TIB53 cells were
maintained in D10 medium: Dulbecco's modified Eagle's
medium (DMEM) (Mediatech, Herndon, VA) supplemented
with 10% fetal bovine serum (FBS) (Hyclone, Logan, UT) and
2 mM glutamine (Gemini Bio-Products, West Sacramento, CA).
IEC-6 cells were maintained in D10 medium supplemented with
0.1 U/ml of bovine insulin (Sigma, St. Louis, MO). K562,
Jurkat, CEM, TB1Lu and CRL1608 cells were maintained in
R10 medium: RPMI (Mediatech) supplemented with 10% FBS
and 2 mM glutamine. Nalm-6 cells were maintained in D10
supplemented with 0.02% β-mercaptoethanol (Sigma) and FBS
tested for B cell culture. Dystroglycan knockout (−/−) R1
murine embryonic stem cells (mES DG-) (Williamson et al.,
1997) were generously provided by Dr. Kevin Campbell
(University of Iowa) and cultured in DMEM supplemented
with 20% FBS, 2 mM glutamine, 1 mM non-essential amino
acids (Chemicon, Temecula, CA), 0.001% β-mercaptoethanol
(Sigma) and 103 U/ml of murine leukemia inhibiting factor
(ESGRO, Chemicon). All cells were maintained in 5% CO2
except TIB27, TIB53, CRL1608, IEC-6 and TB1Lu cells,
which were maintained in 10% CO2.
Retroviral vector production and titer determination
Pseudotyped retroviral vectors displaying arenavirus GPs
were produced as described (Christodoulopoulos and Cannon,
2001; Reignier et al., 2006). The retroviral vector genome used
was pMND-eGFP, which expresses enhanced green fluorescent
protein (eGFP) as a reporter gene. The arenavirus GPs used
were from LASV (Josiah strain, accession no.AY628203),
JUNV (Parodi strain, accession no.U70799), MACV (Carvallo
strain, accession no.AY129248) and TCRV (TRVL 11598
strain, accession no.P31840, with substitutions at two positions,
R233H and E446R) (Reignier et al., 2006). All GPs were cloned
into the expression vector pCAGGS (Niwa et al., 1991).
Vector supernatants were harvested 48 h post-transfection,
filtered through a 0.45-μm filter (Millipore, Bedford, MA) and
stored in aliquots at −80 °C. When necessary, supernatants were
also concentrated by layering over 6 ml of 20% w/v sucrose,
followed by ultracentrifugation at 25,000 rpm for 2 h in a
Beckman SW28 rotor. Titers were determined by incubation of
serially diluted vector stocks with target cells for 48 h, followed
by FACS analysis for eGFP expression and calculation of
percent positive cells. The titer of vector stocks was expressed
as transducing units per milliliter (TU/ml).Immunoadhesin production, Western blot and binding assay
Immunoadhesin constructs were generated by fusing GP1
sequences, including the native signal peptide, upstream of a
rabbit IgG heavy chain Fc sequence (hinge-CH2-CH3), con-
tained in the expression plasmid pSK100 (generously provided
by Dr. J. Young, Salk Institute). 293T cells seeded in poly-L-
lysine-coated 10-cm plates were transiently transfected with
20 μg of plasmid using the calcium phosphate transfection
technique (Christodoulopoulos and Cannon, 2001). Forty-eight
hours post-transfection, supernatants were collected (15 ml per
plate), filtered through 0.45-μm filters, and concentrated using
Centricon Plus-20 30 kDa MWCO centrifugal filter units
(Millipore). Briefly, 19 ml of supernatant was added to each
filter unit and centrifuged at 3000 rpm for 45 min. The units
were reloaded 1 or 2 times with up to 19 ml of additional
supernatant. To elute the immunoadhesins, the units were
inverted and centrifuged for 1 min at 1000 rpm. Eluates were
frozen in 30 μl aliquots at −80 °C until use.
Immunoadhesin production was analyzed by Western blot.
Cell lysates were harvested and 25 μg total protein resolved on
4–20% gradient SDS-polyacrylamide gels (Bio-Rad). Follow-
ing transfer to a PVDF membrane, immunoadhesins were
detected using HRP-conjugated anti-rabbit IgG (Sigma) diluted
1:5000 in phosphate-buffered saline (PBS) plus 0.1% Tween-20
(Sigma), and specific bands were visualized using ECL
detection reagent (GE/Amersham Biosciences, Piscataway,
NJ). To ensure equal protein loading, membranes were also
probed with mouse anti-actin IgG diluted 1:5000, followed by
HRP-conjugated anti-mouse IgG (Sigma) diluted 1:10,000.
The binding activity of each batch of immunoadhesin was
determined by staining 5×105 K562 cells with up to 30 μl of a
thawed aliquot, as described below. This allowed samples to be
normalized between batches. Binding of the immunoadhesins to
various human, rodent and bat cell lines was assayed as follows:
between 5×105 and 1×106 cells were resuspended in blocking
buffer (0.5% bovine serum albumin in PBS) and incubated
20 min on ice. After washing in 1 ml of PBS, cells were
resuspended in an aliquot of thawed immunoadhesin, incubated
30 min on ice, washed again, resuspended in 50 μl of a 1:50
dilution of FITC-conjugated anti-rabbit IgG (BD Pharmingen,
San Jose, CA) in PBS, and incubated 20 min on ice. Cells were
washed twice with 1 ml of PBS, resuspended in 400 μl of 4%
paraformaldehyde and analyzed on a FACSCAN flow cyt-
ometer (BD, Franklin Lakes, NJ). Unstained cells were initially
gated by forward and side scatter (FCS and SSC) to identify the
viable cell population. Cells stained with only the secondary
antibody were analyzed and used to set the gate for the test
samples (R2 population) and the percentage of positive cells in
the R2 population in each test sample was measured.
pH dependence assay
5×105 K562 or 293A cells were pre-treated for 1 h with
50 mM NH4Cl (Sigma). One milliliter of vector supernatant,
containing 50 mM NH4Cl, was added to the cells and incubated
for 2 h. The vector supernatants were removed and the cells
139J. Oldenburg et al. / Virology 364 (2007) 132–139were incubated for 3 h in 2 ml D10 medium containing 50 mM
NH4Cl. The media were then removed, the cells were washed in
PBS, and replated in 2 ml fresh D10 medium (no drug).
Following incubation for a further 48 h, the vector titers were
determined by FACS analysis as described above. Negative (no
drug) controls were run in parallel, and the percentage titer for
the drug treatment arm compared to control cells was calculated
for each vector and cell line combination.
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